Cancer immunotherapy: simply cell biology?

By Colaco C.A.L.S.  

Trends in Molecular Medicine, Vol. 9, Iss. 12, 2003-12 ,pp. : 515-516

Elsevier

Access to resources Recommend Favorite

Ex vivo expansion, maturation, and activation of umbilical cord blood-derived T lymphocytes with IL-2, IL-12, anti-CD3, and IL-7 - Potential for adoptive cellular immunotherapy post-umbilical cord blood transplantation

By Robinson K.L.   Ayello J.   Hughes R.   van de Ven C.   Issitt L.   Kurtzberg J.   Cairo M.S.  

Experimental Hematology, Vol. 30, Iss. 3, 2002-03 ,pp. : 245-251

Elsevier

Access to resources Recommend Favorite

New Perspectives for Melanoma Immunotherapy: Role of IL-12

By  

Current Molecular Medicine, Vol. 9, Iss. 4, 2009-05 ,pp. : 459-469

Bentham Science Publishers

Access to resources Recommend Favorite

IL-23/IL-17 Biology and Therapeutic Considerations

By Dong Chen  

Journal of Immunotoxicology, Vol. 5, Iss. 1, 2008-12 ,pp. : 43-46

Informa Healthcare

Access to resources Recommend Favorite

Conference overview: Cancer Immunotherapy and Immunomonitoring (CITIM): Moving forward

By Malyguine Anatoli   Umansky Victor   Kotlan Beatrix   Aptsiauri Natalia   Shurin Michael R.  

Journal of Immunotoxicology, Vol. 9, Iss. 3, 2012-09 ,pp. : 231-235

Informa Healthcare

Access to resources Recommend Favorite